Zacks Investment Research on MSN

Here's why you should retain DexCom stock in your portfolio for now

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...

Earnings Preview: What To Expect From DexCom's Report

DexCom is expected to announce its second-quarter earnings soon, and Wall Street expects the company’s EPS to increase by a ...
Reuters

Dexcom beats quarterly estimates on strong demand for glucose monitors

Oct 30 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring ...
The Motley Fool

If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today

DexCom develops and markets continuous glucose monitoring (CGM) systems, a type of device that continuously tracks blood sugar levels. The technology isn't exactly new anymore, and it has enjoyed ...
The Motley Fool

Should You Buy DexCom Stock Before Oct. 31?

DexCom is a major player in the continuous glucose monitoring (CGM) market. These devices help diabetes patients monitor their blood sugar levels in real time throughout the day, an activity that is ...
Seeking Alpha

DexCom May Be The Most Underrated Growth Story In Healthcare

DexCom receives a BUY rating due to strong growth, expanding margins, and the launch of Stelo, the first OTC CGM for non-insulin users. DXCM raised its 2025 outlook, targeting $4.6B+ in revenue, 62% ...
Zacks.com on MSN

Here's Why You Should Retain DexCom Stock in Your Portfolio

DexCom, Inc. DXCM is well-positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong first-quarter 2026 ...